Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop
详细信息 查看全文
- 作者：Eric J Lavonas (1) (2) (6)
Anne-Michelle Ruha (3)
William Banner (4) (5)
Vikhyat Bebarta (7)
Jeffrey N Bernstein (7) (8)
Sean P Bush (9)
William P Kerns II (10)
William H Richardson (11) (12)
Steven A Seifert (13) (14)
David A Tanen (15) (16)
Steve C Curry (3)
Richard C Dart (1) (2) - 刊名：BMC Emergency Medicine
- 出版年：2011
- 出版时间：December 2011
- 年：2011
- 卷：11
- 期：1
- 全文大小：995KB
- 参考文献：1. O'Neil ME, Mack KA, Gilchrist J, Wozniak EJ: Snakebite injuries treated in United States emergency departments, 2001鈥?004. / Wilderness Environ Med 2007,18(4):281鈥?87. CrossRef
2. Langley R: Animal-related fatalities in the United States - an update. / Wilderness Environ Med 2005, 16:67鈥?4. CrossRef
3. Spiller HA, Bosse GM, Ryan ML: Use of antivenom for snakebites reported to United States poison centers. / Am J Emerg Med 2010, in press.
4. Walter FG, Stolz U, Shirazi F, McNally J, Walter FG, Stolz U, Shirazi F, McNally J: Epidemiology of severe and fatal rattlesnake bites published in the American Association of Poison Control Centers' Annual Reports. / Clin Toxicol 2009,47(7):663鈥?69. CrossRef
5. Goto CS, Feng SY: Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation. / Pediatr Emerg Care 2009,25(4):273鈥?79. CrossRef
6. Campbell BT, Corsi JM, Boneti C, Jackson RJ, Smith SD, Kokoska ER: Pediatric snakebites: lessons learned from 114 cases. / J Pediatr Surg 2008,43(7):1338鈥?1. CrossRef
7. Gold BS, Dart RC, Barish RA: Bites of venomous snakes. / N Engl J Med 2002,347(5):347鈥?56. CrossRef
8. Dart RC: Can steel heal a compartment syndrome caused by rattlesnake venom? / Ann Emerg Med 2004,44(2):105鈥?07. CrossRef
9. Corneille MG, Larson S, Stewart RM, Dent D, Myers JG, Lopez PP, McFarland MJ, Cohn SM: A large single-center experience with treatment of patients with crotalid envenomations: outcomes with and evolution of antivenin therapy. / Am J Surg 2006,192(6):848鈥?52. CrossRef
10. Tanen D, Ruha A, Graeme K, Curry S: Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary referral center in central Arizona. / Acad Emerg Med 2001,8(2):177鈥?82. CrossRef
11. Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, Kitchens CS, Curry SC, Bogdan GM, / et al.: A randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. / Arch Intern Med 2001,161(16):2030鈥?036. CrossRef
12. Dart RC, Seifert SA, Carroll L, Clark RF, Hall E, Boyer-Hassen LV, Curry SC, Kitchens CS, Garcia RA: Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. / Ann Emerg Med 1997,30(1):33鈥?9. CrossRef
13. Stanford CF, Bebarta VS, Holstege CP, Bush SP, Richardson WH, Olsen D, Dart RC: Is Crotaline Fab Antivenom efficacious for severe envenomations? [abstract]. / Clin Toxicol 2007,45(6):619.
14. Suankratay C, Wilde H, Nunthapisud P, Khantipong M, Suankratay C, Wilde H, Nunthapisud P, Khantipong M: Tetanus after white-lipped green pit viper ( Trimeresurus albolabris ) bite. / Wilderness Environ Med 2002,13(4):256鈥?61. CrossRef
15. Habib A: Tetanus complicating snakebite in northern Nigeria; clinical presentation and public health implications. / Acta Trop 2003,85(1):87鈥?1. CrossRef
16. Anonymous: ACIP Recommendations for Vaccination. [http://www.cdc.gov/vaccines/pubs/acip-list.htm] Atlanta, Georgia: Centers for Disease Prevention and Control; 2010.
17. Russell F: / Snake Venom Poisoning. 3rd edition. Great Neck, NY, Scholium International; 1983.
18. Curry S, Horning D, Brady P, Requa R, Kunkel D, Vance M: The legitimacy of rattlesnake bites in central Arizona. / Ann Emerg Med 1989,18(6):658鈥?63. CrossRef
19. Ownby CL: Structure, function and biophysical aspects of the myotoxins from snake venoms. / J Toxicol - Toxin Rev 1998,17(2):213鈥?38.
20. Gutierrez JM, Rucavado A: Snake venom metalloproteinases: Their role in the pathogenesis of local tissue damage. / Biochimie 2000,82(9鈥?0):841鈥?50. CrossRef
21. Moura-da-Silva A, Laing G, Paine M, Dennison J, Politi V, Crampton J, Theakston D: Processing of pro-tumour necrosis factor-伪 by venom metalloproteinases: a hypothesis towards explaining local tissue damage following snakebite. / Toxicon 1997,35(6):814鈥?15. CrossRef
22. Crocker P, Zad O, Milling T, Maxson T, King B, Whorton E: Human cytokine response to Texas crotaline envenomation before and after antivenom administration. / Am J Emerg Med 2010, in press.
23. Kitchens CS: Hemostatic aspects of envenomation by North American snakes. / Hematol Oncol Clin North Am 1992,6(5):1189鈥?195.
24. Hutton R, Warrell D: Action of snake venom components on the haemostatic system. / Blood Rev 1993,7(3):176鈥?89. CrossRef
25. Boyer LV, Seifert SA, Clark RF, McNally JT, Williams SR, Nordt SP, Walter FG, Dart RC: Recurrent and persistent coagulopathy following pit viper envenomation. / Arch Intern Med 1999,159(7):706鈥?10. CrossRef
26. Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DE, Graeme KA, Wallace K, Gerkin R, Lovecchio F, Wax P, Selden B: Initial postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. / Ann Emerg Med 2002,39(6):609鈥?15. CrossRef
27. Kitchens C, Eskin T: Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome. / J Med Toxicol 2008,4(3):180鈥?83. CrossRef
28. Fazelat J, Teperman SH, Touger M, Fazelat J, Teperman SH, Touger M: Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with Crotalidae polyvalent immune Fab (ovine). / Clin Toxicol 2008,46(9):823鈥?26. CrossRef
29. O'Brien NF, DeMott MC, Suchard JR, Clark RF, Peterson BM: Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation. / Pediatr Emerg Care 2009,25(7):457鈥?59. CrossRef
30. Camilleri C, Offerman S, Gosselin R, Albertson T, Camilleri C, Offerman S, Gosselin R, Albertson T: Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation. / Clin Toxicol 2005,43(3):201鈥?06.
31. Ruha AM, Curry SC, Albrecht C, Riley B, Pizon A: Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune fab antivenom. / Toxicon 2010,57(1):53鈥?. CrossRef
32. Bush SP, Siedenburg E: Neurotoxicity associated with suspected southern Pacific rattlesnake ( Crotalus viridis helleri ) envenomation. / Wilderness Environ Med 1999,10(4):247鈥?49. CrossRef
33. Richardson WH, Goto CS, Gutglass DJ, Williams SR, Clark RF: Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom. / Clin Toxicol 2007,45(5):472鈥?75. CrossRef
34. Clark RF, Williams SR, Nordt SP, Boyer-Hassen LV: Successful treatment of crotalid-induced neurotoxicity with new polyspecific crotalid Fab antivenom. / Ann Emerg Med 1997,30(1):54鈥?7. CrossRef
35. Glenn JL, Straight RC, Wolfe MC, D L: Geographical variation in Crotalus scutulatus scutulatus (Mojave rattlesnake) venom properties. / Toxicon 1983,21(1):119鈥?30. CrossRef
36. Lavonas EJ, Schaefer TH, Kokko J, Mlynarchek SL, Bogdan GM: Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review. / BMC Emerg Med 2009.,9(13): epub
37. Lavonas EJ, Kokko J, Schaeffer TH, Mlynarchek SL, Bogdan GM, Dart RC: Short-term outcomes following Fab antivenom therapy for severe crotaline snakebite. / Ann Emerg Med 2010,57(2):128鈥?37. CrossRef
38. Lavonas EJ, Kerns WP, Gerardo CJ, Richardson W, Whitlow KS, Berkoff DJ: Long-term limb function outcomes after copperhead snakebite [abstract]. / Ann Emerg Med 2008,52(4):S141鈥?42. CrossRef
39. Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD: Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes ( Crotalus helleri ). / Ann Emerg Med 2002,40(6):619鈥?24. CrossRef
40. Lavonas EJ, Gerardo CJ, O'Malley G, Arnold TC, Bush SP, Banner W, Steffens M, Kerns WP: Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. / Ann Emerg Med 2004,43(2):200鈥?06. CrossRef
41. Yin S, Kokko J, Lavonas E, Mlynarchek S, Bogdan G, Schaeffer T: Factors associated with difficulty achieving initial control with Crotalidae Polyvalent Immune Fab antivenom in snakebite patients. / Acad Emerg Med 2010,18(1):46鈥?2. CrossRef
42. Offerman S, Barry J, Richardson W, Tong T, Tanen D, Bush S, Clark R: Subcutaneous crotaline Fab antivenom for the treatment of rattlesnake envenomation in a porcine model. / Clin Toxicol 2009,47(1):61鈥?8. CrossRef
43. Anonymous: Prescribing Information: CroFab 庐 . [http://www.btgplc.com/PubContent/Docs/CroFab%20PI.pdf]
44. Cannon R, Ruha AM, Kashani J: Acute hypersensitivity reactions associated with administration of Crotalidae polyvalent immune Fab antivenom. / Ann Emerg Med 2008,51(4):407鈥?11. CrossRef
45. Holstege CP, Wu J, Baer AB: Immediate hypersensitivity reaction associated with the rapid infusion of Crotalidae polyvalent immune Fab (ovine). / Ann Emerg Med 2002,39(6):677鈥?79. CrossRef
46. Janes D, Bush S, Kolluru G: Large snake size suggests increased snakebite severity in patients bitten by rattlesnakes in southern California. / Wilderness Environ Med 2010,21(2):120鈥?26. CrossRef
47. Offerman SR, Bush SP, Moynihan JA, Clark RF, Offerman SR, Bush SP, Moynihan JA, Clark RF: Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. / Pediatrics 2002,110(5):968鈥?71. CrossRef
48. Schmidt JM, Schmidt JM: Antivenom therapy for snakebites in children: is there evidence? / Curr Opin Pediatr 2005,17(2):234鈥?38. CrossRef
49. Chuang R, Kokko J, Mlynarchek S, Schaeffer T, Bogdan G, Lavonas E: Rattlesnake versus Agkistrodon envenomations: venom effects differences [abstract]. In / Abstracts from Venom Week 2009, June 1鈥?, 2009 Albuquerque NM. J Med Toxicol Edited by: Seifert SA. 2010,6(2):240鈥?.
50. Offerman SR, Barry JD, Schneir A, Clark RF: Biphasic rattlesnake venom-induced thrombocytopenia. / J Emerg Med 2003,24(3):289鈥?93. CrossRef
51. Lintner C, Keyler D, Bilden E: Prairie rattlesnake ( Crotalus viridis viridis ) envenomation: recurrent coagulopathy in a child treated with immune Fab [abstract]. In / Snakebites in the new millennium. Proceedings of a state-of-the-art symposium. J Med Toxicol Edited by: Seifert SA. 2006,2(1):33鈥?.
52. Seifert SA, Boyer LV, Dart RC, Porter RS, Sjostrom L: Relationship of venom effects to venom antigen and antivenom serum concentrations in a patient with Crotalus atrox envenomation treated with a Fab antivenom. / Ann Emerg Med 1997,30(1):49鈥?3. CrossRef
53. Hurlbut K, Dart R, Spaite D, McNally J: Reliability of clinical presentation for predicting significant pit viper envenomation. / Ann Emerg Med 1988,17(4):438鈥?39.
54. Miller MA, Dyer JE, Olson KR: Two cases of rattlesnake envenomation with delayed coagulopathy. / Ann Emerg Med 2002,39(3):348. CrossRef
55. Wasserberger J, Ordog G, Merkin TE: Southern Pacific rattlesnake bite: a unique clinical challenge. / J Emerg Med 2006,31(3):263鈥?66. CrossRef
56. Kerns W, Tomaszewski C: Airway obstruction following canebrake rattlesnake envenomation. / J Emerg Med 2001,20(4):377鈥?80. CrossRef
57. Boyer LV, Seifert SA, Cain JS: Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom. / Ann Emerg Med 2001,37(2):196鈥?01. CrossRef
58. Ruha AM, Curry SC: Recombinant factor VIIa for treatment of gastrointestinal hemorrhage following rattlesnake envenomation. / Wilderness Environ Med 2009,20(2):156鈥?60. CrossRef
59. Gutierrez JM, Rucavado A, Escalante T, Diaz C: Hemorrhage induced by snake venom metalloproteinases: Biochemical and biophysical mechanisms involved in microvessel damage. / Toxicon 2005,45(8):997鈥?011. CrossRef
60. Yip L: Rational use of Crotalidae polyvalent immune Fab (ovine) in the management of crotaline bite. / Ann Emerg Med 2002,39(6):648鈥?50. CrossRef
61. Kitchens C, Hunter S, Van Mierop L: Severe myonecrosis in a fatal case of envenomation by the canebrake rattlesnake ( Crotalus horridus atricaudatus ). / Toxicon 1987,25(4):455鈥?58. CrossRef
62. Curry S, Kraner J, Kunkel D, Ryan P, Vance M, Requa R, Ruggieri S: Noninvasive vascular studies in management of rattlesnake envenomations to extremities. / Ann Emerg Med 1985,14(11):1081鈥?084. CrossRef
63. Tanen D, Danish D, Grice G, Riffenburgh R, Clark R: Fasciotomy worsens the amount of myonecrosis in a porcine model of crotaline envenomation. / Emerg Med 2004,44(2):99鈥?04.
64. Shaw BA, Hosalkar HS: Rattlesnake bites in children: Antivenin treatment and surgical indications. / J Bone Joint Surg 2002,84(9):1624鈥?629.
65. Curry S, O'Connor A, Ruha A: Rapid-onset shock and/or anaphylactoid reactions from rattlesnake bites in central Arizona. / Clin Toxicol 2010, in press.
66. Litovitz T, Klein-Schwartz W, Rodgers G, Cobaugh D, Youniss J, Omslaer J, May M, Woolf A, Benson B: 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. / Am J Emerg Med 2002,20(5):391鈥?52. CrossRef
67. Lai M, Klein-Schwartz W, Rodgers G, Abrams J, Haber D, Bronstein A, Wruk K: 2005 Annual report of the American Association of Poison Control Centers' National Poisoning and Exposure Database. / Clin Toxicol 2006, 44:803鈥?32. CrossRef
68. Ownby C, Colberg T, Odell G: In vivo ability of antimyotoxin a serum plus polyvalent ( Crotalidae ) antivenom to neutralize prairie rattlesnake ( Crotalus viridis viridi s) venom. / Toxicon 1986,24(2):197鈥?00. CrossRef
69. Clark RF, Selden BS, Furbee B: The incidence of wound infection following crotalid envenomation. / J Emerg Med 1993,11(5):583鈥?86. CrossRef
70. Angel MF, Zhang F, Jones M, Henderson J, Chapman SW, Angel MF, Zhang F, Jones M, Henderson J, Chapman SW: Necrotizing fasciitis of the upper extremity resulting from a water moccasin bite. / South Med J 2002,95(9):1090鈥?094.
71. Scharman EJ, Noffsinger VD: Copperhead snakebites: clinical severity of local effects. / Ann Emerg Med 2001,38(1):55鈥?1. CrossRef
72. Alberts MB, Shalit M, LoGalbo F: Suction for venomous snakebite: a study of "mock venom" extraction in a human model. / Ann Emerg Med 2004,43(2):181鈥?86. CrossRef
73. Bush SP, Hegewald KG, Green SM, Cardwell MD, Hayes WK: Effects of a negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in a porcine model. / Wilderness Environ Med 2000,11(3):180鈥?. CrossRef
74. Cohen W, Wetzel W, Kadish A: Local heat and cold application after eastern cottonmouth moccasin ( Agkistrodon piscivorus ) envenomation in the rat: effect on tissue injury. / Toxicon 1992,30(11):1383鈥?386. CrossRef
75. Frank H: What are we doing? An evaluation of cryotherapy for envenomation. / Western J Med 1971,114(5):25鈥?7.
76. Guderian R, Mackenzie C, Williams J: High voltage shock treatment for snake bite. / Lancet 1986, 2:229. CrossRef
77. Dart RC, Gustafson RA: Failure of electric shock treatment for rattlesnake envenomation. / Ann Emerg Med 1991,20(6):659鈥?61. CrossRef
78. Johnson E, Kardong KV, Mackessy SP: Electric shocks are ineffective in the treatment of lethal effects of rattlesnake envenomation in mice. / Toxicon 1987,25(12):1347鈥?349. CrossRef
79. Howe NR, Meisenheimer JL: Electric shock does not save snakebitten rats. / Ann Emerg Med 1988,17(3):254鈥?56. CrossRef
80. Welch B, Gales BJ: Use of stun guns for venomous bites and stings: a review. / Wilderness Environ Med 2001,12(2):111鈥?17. CrossRef
81. Gold BS: Electric shock: a potentially hazardous approach to treating venomous snakebite. / Maryland Med J 1993,42(3):244鈥?45.
82. Reid H, Thean P, Martin W: Specific antivenin and prednisone in viper-bite poisoning: controlled trial. / BMJ 1963,2(5369):1387鈥?380. CrossRef
83. Reid H, Theakston R: The management of snake bite. / Bull World Health Organ 1983,61(6):885鈥?95.
84. Amaral CFS, Campolina D, Dias MB, Bueno CM, Rezende NA: Tourniquet ineffectiveness to reduce the severity of envenoming after Crotalus durissus snake bite in Belo Horizonte, Minas Gerais, Brazil. / Toxicon 1998,36(5):805鈥?08. CrossRef
85. Bush S, Green S, Laack T, Hayes W, Cardwell M, Tanen D: Pressure immobilization delays mortality and increases intracompartmental pressure after artificial intramuscular rattlesnake envenomation in a porcine model. / Ann Emerg Med 2004,44(6):599鈥?04. CrossRef
86. Meggs W, Courtney C, O'Rourke D, Brewer K: Pilot studies of pressure-immobilization bandages for rattlesnake envenomations. / Clin Toxicol 2010,48(1):61鈥?3. CrossRef
87. Burgess J, Dart R, Egen N, Mayersohn M: Effects of constriction bands on rattlesnake venom absorption: A pharmacokinetic study. / Ann Emerg Med 1992,21(9):1086鈥?093. CrossRef
88. Anonymous: The efficacy of Crotaline Fab antivenom for copperhead snake envenomations - clinical trial. [http://www.clinicaltrials.gov/ct2/show/NCT00868309] / [Clinical trial identifier NCT00303303] accessed July 1, 2010
89. Anonymous: A comparison of Crotalinae (pit viper) equine immune F(ab)2 antivenom (Anavip) and Crotalidae polyvalent immune Fab, ovine antivenom (CroFab) in the treatment of pit viper envenomation. [http://www.clinicaltrials.gov/ct2/results?term=00868309] / [Clinical trial identifier NCT00868309] accessed July 1, 2010
90. Anonymous: Phase 3 multicenter comparative study to confirm safety and effectiveness of the F(ab)2 antivenom Anavip. [http://www.clinicaltrials.gov/ct2/results?term=NCT00636116] / [Clinical trial identifier NCT00636116] accessed July 1, 2010
91. Guyatt G, Oxman A, Kunz R, Falck-Yttr Y, Vist G, Liberati A, Schunemann H: Rating quality of evidence and strength of recommendations: Going from evidence to recommendations. / BMJ 2008, 336:1049鈥?051. CrossRef
92. Weant K, Johnson P, Bowers R, Armistead J: Evidence-based, multidisciplinary approach to the development of a Crotalidae polyvalent antivenin (CroFab) protocol at a university hospital. / Ann Pharmacother 2010, 44:447鈥?55. CrossRef
93. Cribari C: Management of poisonous snakebite. [http://www.facs.org/trauma/publications/snakebite.pdf] Chicago: American College of Surgeons Committee on Trauma; 2004.
94. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-227X/11/2/prepub - 作者单位：Eric J Lavonas (1) (2) (6)
Anne-Michelle Ruha (3)
William Banner (4) (5)
Vikhyat Bebarta (7)
Jeffrey N Bernstein (7) (8)
Sean P Bush (9)
William P Kerns II (10)
William H Richardson (11) (12)
Steven A Seifert (13) (14)
David A Tanen (15) (16)
Steve C Curry (3)
Richard C Dart (1) (2)
1. Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, Colorado, USA
2. Division of Medical Toxicology, Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA
6. Department of Emergency Medicine, Wilford Hall Medical Center, San Antonio, Texas, USA
3. Department of Medical Toxicology, Banner Good Samaritan Medical Center, Phoenix, Arizona, USA
4. Oklahoma Poison Center, College of Pharmacy, University of Oklahoma, Oklahoma City, Oklahoma, USA
5. Pediatric Intensive Care Unit, Integris Baptist Medical Center, Oklahoma City, Oklahoma, USA
7. Florida Poison Information Center, Miami, Florida, USA
8. Emergency Care Center, Jackson Memorial Hospital, Miami, Florida, USA
9. Department of Emergency Medicine, Loma Linda University School of Medicine, Loma Linda, California, USA
10. Division of Medical Toxicology, Department of Emergency Medicine and Carolinas Poison Center, Carolinas Medical Center, Charlotte, North Carolina, USA
11. Department of Emergency Medicine, Palmetto Health Richland, Columbia, South Carolina, USA
12. Palmetto Poison Center, University of South Carolina, Columbia, South Carolina, USA
13. New Mexico Poison and Drug Information Center, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA
14. Department of Emergency Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
15. Naval Medical Center, San Diego, California, USA
16. Division of Medical Toxicology, Department of Emergency Medicine, University of California at San Diego, San Diego, California, USA
文摘
Background Envenomation by crotaline snakes (rattlesnake, cottonmouth, copperhead) is a complex, potentially lethal condition affecting thousands of people in the United States each year. Treatment of crotaline envenomation is not standardized, and significant variation in practice exists. Methods A geographically diverse panel of experts was convened for the purpose of deriving an evidence-informed unified treatment algorithm. Research staff analyzed the extant medical literature and performed targeted analyses of existing databases to inform specific clinical decisions. A trained external facilitator used modified Delphi and structured consensus methodology to achieve consensus on the final treatment algorithm. Results A unified treatment algorithm was produced and endorsed by all nine expert panel members. This algorithm provides guidance about clinical and laboratory observations, indications for and dosing of antivenom, adjunctive therapies, post-stabilization care, and management of complications from envenomation and therapy. Conclusions Clinical manifestations and ideal treatment of crotaline snakebite differ greatly, and can result in severe complications. Using a modified Delphi method, we provide evidence-informed treatment guidelines in an attempt to reduce variation in care and possibly improve clinical outcomes.